Matrix implant

Information

  • Patent Grant
  • 12161374
  • Patent Number
    12,161,374
  • Date Filed
    Monday, July 26, 2021
    3 years ago
  • Date Issued
    Tuesday, December 10, 2024
    11 days ago
Abstract
Implants for the fusion or fixation of two bone segments are described. For example, the implants can be used for the fusion or fixation of the sacroiliac joint. The implants can have a matrix structure, have a rectilinear cross-sectional area, and have a curvature.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


FIELD

Embodiments of the invention relate generally to bone implants that can be used to fuse two bone segments together.


BACKGROUND

Many types of hardware are available both for the fixation of bones that are fractured and for the fixation of bones that are to be fused (arthrodesed).


For example, the human hip girdle (see FIGS. 1 and 2) is made up of three large bones joined by three relatively immobile joints. One of the bones is called the sacrum and it lies at the bottom of the lumbar spine, where it connects with the L5 vertebra. The other two bones are commonly called “hip bones” and are technically referred to as the right ilium and—the left ilium. The sacrum connects with both hip bones at the sacroiliac joint (in shorthand, the SI-Joint).


The SI-Joint functions in the transmission of forces from the spine to the lower extremities, and vice-versa. The SI-Joint has been described as a pain generator for up to 22% of lower back pain patients.


To relieve pain generated from the SI-Joint, sacroiliac joint fusion is typically indicated as surgical treatment, e.g., for degenerative sacroiliitis, inflammatory sacroiliitis, iatrogenic instability of the sacroiliac joint, osteitis condensans ilii, or traumatic fracture dislocation of the pelvis. Currently, screws and screws with plates are used for sacro-iliac fusion. At the same time the cartilage has to be removed from the “synovial joint” portion of the SI-Joint. This requires a large incision to approach the damaged, subluxed, dislocated, fractured, or degenerated joint. The large incision and removal of tissue can cause significant trauma to the patient, resulting in pain and increasing the time to heal after surgery.


In addition, screw type implants tend to be susceptible to rotation and loosening, especially in joints that are subjected to torsional forces, such as the SI-Joint. Excessive movement of the implant after implantation may result in the failure of the implant to incorporate and fuse with the bone, which may result in the need to remove and replace the failed implant.


Consequently, it would be desirable to provide an implant for bone fusion or fixation that resists rotation, can be implanted using a minimally invasive procedure, and/or that can be used to rescue a failed implant.


SUMMARY OF THE DISCLOSURE

The present invention relates generally to bone implants that can be used to fuse two bone segments together.


In some embodiments, an implant for the fixation or fusion of the SI-Joint is provided. The implant can include an elongate body having a longitudinal axis and a rectilinear cross-sectional profile transverse to the longitudinal axis, the elongate body having a proximal end and a distal end. The elongate body can include a plurality of apex struts aligned with the longitudinal axis and extending between the proximal end and the distal end of the elongate body; a plurality of support struts that extend from one apex strut to another apex strut to form a matrix structure; and a first guide pin receptacle located along the longitudinal axis of the elongate body.


In some embodiments, the rectilinear cross-sectional profile is triangular.


In some embodiments, the rectilinear cross-sectional profile is rectangular or square.


In some embodiments, the elongate body is curved along the longitudinal axis from the proximal end to the distal end of the elongate body. In some embodiments, the elongate body has a curvature between about 5 and 45 degrees.


In some embodiments, the elongate body has a curvature between about 15 and 30 degrees.


In some embodiments, the guide pin receptacle has a circular opening adapted to securely receive a guide pin.


In some embodiments, the elongate body is coated with a titanium plasma spray.


In some embodiments, the elongate body is coated with hydroxyapatite.


In some embodiments, the elongate body is made of metal.


In some embodiments, the metal is titanium.


In some embodiments, the metal comprises a lattice structure.


In some embodiments, the lattice structure is cubic.


In some embodiments, the lattice structure is hexagonal.


In some embodiments, the lattice structure comprises a plurality of beams with a diameter between about 100 to 1000 microns.


In some embodiments, the elongate body is made of a ceramic material.


In some embodiments, the elongate body is mode of a plastic material.


In some embodiments, the elongate body has a porous outer surface.


In some embodiments, all struts are covered in a porous surface.


In some embodiments, all struts are preferentially covered in a porous surface.


In some embodiments, the porous outer surface has a pore size between about 100 to 1000 microns.


In some embodiments, the thickness of the apex struts and the support struts is between about 1 to 5 mm.


In some embodiments, the first guide pin receptacle is located at the distal end of the elongate body.


In some embodiments, the first guide pin receptacle is located at the proximal end of the elongate body.


In some embodiments, the first guide pin receptacle is located at the distal end of the elongate body and a second guide pin receptacle is located at the proximal end of the body.


In some embodiments, the implant can further include a continuous cannula extending between the first guide pin receptacle and the second guide pin receptacle.


In some embodiments, a third guide pin receptacle is located between the first guide pin receptacle and the second guide pin receptacle.


In some embodiments, a plurality of pin receptacles are located between the first guide pin receptacle and the second guide pin receptacle.


In some embodiments, a modular implant for the fixation or fusion of the SI-Joint is provided. The modular implant includes a distal portion comprising a frame, the frame joined to a distal guide pin receptacle and to a plurality of transverse support struts arranged in a rectilinear configuration; a proximal portion comprising a frame joined to a proximal guide pin receptacle and to a plurality of transverse support struts arranged in a rectilinear configuration; and at least one repeating internal portion. The at least one repeating internal portion comprises a plurality of apex struts joined together by oblique support struts arranged in an oblique configuration between the apex struts, a plurality of transverse support struts arranged perpendicularly to the apex struts, the plurality of transverse support struts arranged in a rectilinear configuration at both a proximal end and a distal end of the repeating internal portion, and an internal guide pin receptacle secured to the support struts and aligned with both the distal guide pin receptacle and the proximal guide pin receptacle; wherein the at least one internal repeating portion is positioned between the distal portion and the proximal portion such that the transverse support struts of the distal portion are aligned with a first set of transverse support struts of the repeating internal portion and the transverse support struts of the proximal portion are aligned with the a second set of transverse support struts of the repeating internal portion.


In some embodiments, the oblique supports struts are arranged in an “X” configuration. In some embodiments, the oblique supports struts are arranged in a non-overlapping diagonal configuration.


In some embodiments, the apex and support struts are arranged and spaced to accept bone graft material from the outer surface toward the center of the implant.


In some embodiments, the graft material is autograft.


In some embodiments, the graft material is allograft.


In some embodiments, the graft material is bone morphogenetic protein.


In some embodiments, the implant does not have any struts that extend from the outer surface toward the center of the implant, thereby forming a cavity for receiving a graft material and/or guide pin.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIGS. 1 and 2 are, respectively, anterior and posterior anatomic views of the human hip girdle comprising the sacrum and the hip bones (the right ilium, and the left ilium), the sacrum being connected with both hip bones at the sacroiliac joint (in shorthand, the SI-Joint).



FIGS. 3 and 4 are embodiments of various straight implants that can be used for the fusion or fixation of a joint or two bone segments.



FIG. 5 illustrates an axial section view of the SI-Joint with an implant for the fixation of the SI-Joint using a lateral approach that goes laterally through the ilium, the SI-Joint, and into the sacrum 51.



FIG. 6 illustrates an axial section view of the SI-Joint with an implant for the fixation of the SI-Joint using a postero-lateral approach entering from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the sacral alae.



FIGS. 7A-7C illustrate various embodiments of implants having a matrix structure formed from a plurality of struts.



FIGS. 7D-7F illustrate various embodiments of implants having a matrix structure with a plurality of pin receptacles.



FIGS. 7G-7I illustrate another embodiment of an implant having a matrix structure from various angles and cross-sections.



FIG. 8 illustrates an embodiment of a fenestrated implant.



FIGS. 9A-9D illustrate various cross-sectional profiles of the implant microstructure, which can be formed with beam microstructures of varying geometries.



FIGS. 10A-10C illustrate various alternative beam microstructures.



FIGS. 11A-11D illustrate various sizes for the beams that form the implant microstructure.



FIG. 12 illustrates an embodiment of a curved matrix implant.



FIG. 13 illustrates an embodiment of a modular matrix implant.





DETAILED DESCRIPTION


FIG. 3 and FIG. 4 illustrate straight implants 10 with a solid elongate body 12 that can be used for the fixation or fusion of two bone segments. The implant 10 shown in FIG. 3 is cylindrical and can optionally have screw threads along the exterior of the implant body. As mentioned above, cylindrical screw type implants can suffer from excessive rotation. One solution to this problem is the implant 10 in FIG. 4, which has a non-cylindrical cross-sectional area. For example, as shown, the implant 10 can have a triangular cross-sectional area, although other rectilinear cross-sectional profiles may be used as well, including rectangular, hexagonal and the like. Non-cylindrical implants need not have a strict rectilinear cross-sectional profile in order to resist rotation. A cross-sectional area that is non-circular will generally suffice. For example, a tear drop shaped cross-sectional area, or a cross-sectional area with at least one apex, can resist rotation. Other non-circular cross-sectional geometries that may not have a rectilinear component can also work, such as oval cross-sections.



FIG. 5 illustrates insertion of the implant 10 of FIG. 3 or FIG. 4 across the SI-Joint using a lateral approach that goes laterally through the ilium, across the SI-Joint, and into the sacrum. FIG. 6 illustrates insertion of the same implant across the SI-Joint using a postero-lateral approach entering from the posterior iliac spine of the ilium, angling through the SI-Joint, and terminating in the sacral alae. Many of the implants described herein can be inserted across the SI-Joint in a similar manner.


Matrix Implant


In some embodiments, it may be desirable to provide an implant with an open frame structure that can be packed with bone graft material and/or a biologic aid, while providing enough strength to facilitate the fusion of a joint or two bone segments without implant bending or failure.


One way to provide an open frame structure is to construct the elongate body 12 of the implant 10 using a matrix structure, as illustrated in FIGS. 7A-7C and 7G-7I. In some embodiments, each face or side of the elongate body 12 can be constructed using a matrix structure. The implant 10 can have a rectilinear overall cross-sectional profile transverse to a longitudinal axis that extends through the length of the elongate body 12. Each corner or apex of elongate body 12 can be formed with an apex strut 14 that extends between the proximal end 16 and the distal end 18 of the elongate body 12. An implant with a triangular overall cross-sectional profile has three apex struts, while an implant with a square or rectangular overall cross-sectional profile has four apex struts, and so on. To form the faces of the implant, support struts 20 can be arranged in various matrix structures.


For example, FIG. 7A illustrates one embodiment of a matrix structure where the support struts 20 extend diagonally between two apex struts 14 and cross each other in an “X” configuration such that the support struts 20 define triangular and square openings. Additional transverse support struts that extend between two apex struts at a right angle to both apex struts can also be added. The transverse support struts can be positioned between the “X” support struts and/or can be positioned to cross the middle or intersection of the “X” support struts.



FIG. 7B illustrates another embodiment of a matrix structure where the support struts 20 are arranged in an alternating diagonal and transverse pattern. In this embodiment, the diagonal support struts on one face of the implant are all angled in the same direction such that the diagonal support struts are parallel to each other. The support struts 20 define triangular openings.



FIG. 7C illustrates yet another embodiment of a matrix structure where the support struts 20 are arranged in an alternating diagonal and transverse pattern. In this embodiment, the diagonal support struts are angled in an alternating pattern such that the diagonal support struts are oriented about 90 degrees to one another to form a zigzag pattern. The support struts 20 also define triangular openings.


The various matrix structures can provide different levels of resistance to various forces that the implant will be subjected to, including compressive, tensile, shear, bending, and torsional forces.



FIG. 8 illustrates an alternative to using a matrix structure to provide openings. The implant 10 can have an elongate body 12 with fenestrations 22. The fenestrations 22 can be circular as shown, and can be of different sizes in, for example, an alternating pattern of large and small fenestrations. The fenestrations 22 can alternatively be rectilinear in shape, such as triangular, square, rectangular, and the like, or curvilinear, such as elliptical, oval, or circular.


In some embodiments, the fenestrations 22 can be triangular, square, rectangular or combinations of the above and can be arranged to form a matrix structure. In other words, the openings in FIGS. 7A-7B defined by the support struts 20 can be considered fenestrations 22.


The walls of elongate body 12 can be planar and, as described above, can be formed from support struts 20 and/or fenestrations 22, as shown in FIGS. 7G-7I, for example. Using planar walls to form the elongate body 12 can result in a hollow cavity with the same or similar cross-sectional profile as the overall implant. For example, an implant with a triangular overall cross-sectional profile can also have a cavity with a triangular cross-sectional profile. The thickness of the walls and the apex struts and support struts can be between about 1 mm and 5 mm, or between about 1 and 3 mm. In addition, the distal ends of the walls can be tapered.


To facilitate the use of a traditional guide pin with these implants, the distal end of the implant can include a distal guide pin receptacle 24 with an opening 26 that is sized and shaped to receive a guide pin, as shown in FIGS. 7A-8. For example, the opening 26 can be circular to receive a typical guide pin. In some embodiments, the proximal end can additionally or alternatively have a proximal guide pin receptacle with an opening sized and shaped to receive a guide pin. In some embodiments, a continuous cannula can extend from the proximal guide pin receptacle to the distal guide pin receptacle. In some embodiments, multiple individual and co-linear guide pin receptacles can be present within the implant body between the proximal guide pin receptacle and the distal guide pin receptacle.


For example, FIG. 7D illustrates another embodiment of a matrix structure, similar to the embodiment shown in FIG. 7A, with support struts 20 that extend diagonally between apex struts 14 in an “X” configuration. However, in this embodiment, the implant 10 has a proximal guide pin receptacle 28 located at the proximal end of the implant, a distal guide pin receptacle 24 located at the distal end of the implant, and a plurality of internal guide pin receptacles 30 also located along the longitudinal axis of the implant. The internal guide pin receptacles 30 can be attached to the support struts 20 and/or apex struts 14. As shown, the internal guide pin receptacles 30 are attached at the intersection points of the “X” shaped support struts 20. In addition to receiving the guide pin, the internal guide pin receptacles 30 can provide additional support and bracing to the matrix structure.



FIG. 7E illustrates another embodiment of a matrix structure that is similar to the embodiment shown in FIG. 7D. Both embodiments have “X” shaped support struts 20 and a plurality of internal guide pin receptacles 30. However, this embodiment has additional support struts 20 that extend transversely between the apex struts 14 at right angles. The transverse support struts can be positioned between the “X” shaped support struts as shown, or can be integrated into the “X” shaped support struts. The transverse support struts can provide additional support and bracing to the matrix structure.



FIG. 7F illustrates another embodiment of a matrix structure that is similar to the embodiment shown in FIG. 7D. However, instead of having a plurality of guide pin receptacles, the implant 10 has a single guide pin receptacle 32 that extends from the proximal end to the distal end of the implant. This guide pin receptacle 32 can be a tube or cannula that can be attached to the support struts 20. In some embodiments, the tube or cannula can also have a plurality of fenestrations 34. In some embodiments, the fenestrations 34 can be positioned along the openings of the support struts, which allows the tube to support the support struts 20 while fenestrations promote bony ingrowth and allow the introduction of bone graft material through the implant.



FIGS. 7G-7I illustrates another embodiment of a matrix structure that is similar to the embodiment shown in FIG. 7E. This embodiment also has “X” shaped support struts 20 and additional support struts 20 that extend transversely between the apex struts 14 at right angles. One difference between this embodiment and the embodiment illustrated in FIG. 7E is that the support struts 20 and apex struts 14 in this embodiment have generally rectilinear cross-sectional profiles while the embodiment disclosed in FIG. 7E has generally circular support struts 20 and apex struts 14. In some embodiments, the apex struts 14 can be chamfered to remove sharp edges and the apices of the implant. In addition, this embodiment can have a distal guide pin receptacle 24 and a proximal guide pin receptacle, but unlike some of the embodiments described above, can lack internal guide pin receptacles. The guide pin can instead be supported internally by the inherent cross-sectional geometry of the apex struts and/or support struts. Any of the embodiments herein can have rectilinear, circular, or a combination of the two cross-sectional profiles. The use of the rectilinear struts may allow for the fabrication of the matrix implant by laser cutting a walled structure, while tubular struts may be welded together. A laser cut structure may be structurally stronger than a welded structure, which is important for supporting the large loads applied to the implant after implantation. The distal end 18 of the implant 10 can also have one or more openings 29 that allow graft material to be injected distally through the implant after implantation. In addition, any of the embodiments described herein can optionally have the internal guide pin receptacles, or omit the internal guide pin receptacles. FIG. 7H illustrates a cross-sectional view taken through the transverse struts, while FIG. 7I illustrates a cross-sectional view taken through the “X” shaped support struts.


The implant, including the apex struts and/or support struts of the matrix as well as the beams that form the microstructure, can have a variety of shapes. For example, the beams and/or struts can have a cross-section that is rectilinear, curvilinear, or combinations of the two, as illustrated in FIGS. 9A-9D. For example, the beams and/or struts can have a circular cross-section as shown in FIG. 9A, or a curvilinear cross-section as shown in FIGS. 9B and 9C, or a square or rectangular cross section as shown in FIG. 9D. It should be understood that the corners and edges of the beams and/or struts can be rounded off if desired.


The implant can be made of a variety of materials. For example, the implant can be made of a metal or metal alloy, such as titanium or steel, or a nonmetallic material such as ceramic or polymer. In some embodiments, the implant material can have a certain lattice microstructure formed from the beam microparticles. For example, the lattice microstructure of the apex strut, support struts and other parts of the implant can result in a rough or smooth surface texture, depending on the surface finishing techniques used, such as polishing or application of a metal plasma spray, and the size and shape of the beams that form the lattice microstructure. For example, FIGS. 10A-10C illustrate various beam microstructures that can form the lattice microstructure. FIG. 10A illustrates a cubic beam structure, while FIG. 10B illustrates a hexagonal beam structure, and FIG. 10C illustrates an octagonal beam structure. Other beam structures include tetragonal, rhombohedral, orthorhombic, monoclinic, and triclinic. FIGS. 11A-11D illustrate that the beams can have various sizes. For example, FIGS. 11A-11D illustrate beams having a diameter of about 100, 200 microns, 350 microns, 500 microns, and 1000 microns. In other embodiments, the size of the beam can vary between 50 microns to 5000 microns.


The matrix implant can be manufactured using a variety of techniques. For example, the matrix implant can be 3-D printed using a rapid prototyping technique involving additive manufacturing, such as described in U.S. Patent Publication No. 2010/0161061, which is herein incorporated by reference in its entirety for all purposes. The 3-D printed matrix implant can be made of a metal, polymer, or ceramic material. For example, a metal powder such as titanium powder can be fused together to form the implant structure. Other techniques include cutting out the fenestrations or openings, using a laser for example, to form the apex struts and support struts, or using electric discharge machining (EDM) to create the matrixes or fenestrations.


3-D printing allows the porosity of the implant to be controlled. For example, the implant can have a volume porosity between about 30 and 70 percent, with an average pore size between 100 and 1000 microns. The pores can be largely interconnected, largely unconnected, or a mix of interconnected and unconnected pores. In some embodiments, the pores can be located throughout the material of the implant, including the apex struts and support struts, and on all or some of the strut surfaces, including the inner and outer implant surfaces. For example, the fusion of the beam microparticles to form the struts can result in a porous, semi-porous, or nonporous structure, depending on the degree of fusion between the beam microparticles. In other embodiments, the pores can be located in a porous coating that can be applied onto the implant. For example, a porous coating can be applied using a titanium plasma spray process, or another metal plasma spray process. The coating can be applied to the outer surfaces of the implant, the interior surfaces of the implant, or both the outer and interior surfaces of the implant. For example, the coating could be preferentially applied to the outer surface of a matrixed implant to provide bony ingrowth and ongrowth, and not applied to the inner portion of the implant to maximize bony through-growth within the implant. Also, the coating can be applied preferentially from proximal to distal, or vice versa. The thickness of a porous coating can be between about 500 and 1,500 microns. In addition or alternatively to the porous metal coating, a hydroxyapatite coating can also be applied to the implant. In some embodiments, the porosity can be varied along the length of the implant. In some embodiments, the thickness of the coating can be varied along the length of the implant. In some embodiments, the thickness of the coating applied to the outer surface can be different than the thickness of the inner coating. For example, the outer coating may be greater than the inner coating in some embodiments. In other embodiments, the thickness of the inner and outer coatings can be the same.


In some embodiments, as illustrated in FIG. 12, the apex struts 14 can be curved from the proximal end to the distal end of the apex strut 14, thereby resulting in a curved matrix implant 10 similar to the curved implants described in co-pending U.S. Provisional Application No. 62/052,318, filed Sep. 18, 2014 and entitled “IMPLANTS FOR BONE FIXATION OR FUSION,” which is herein incorporated by reference in its entirety for all purposes.


The length of the implant can vary between about 25 to 95 mm. The matrix structure can be modular, as shown in FIG. 13, which allows the length of the implant to be varied by the addition of additional repeating subunits during the design and/or fabrication of the implant. For example, the modular matrix implant 130 can have a distal end portion 132, a proximal end portion 134, and one or more repeating internal portions 136. The distal end portion 132 can have a distal guide pin receptacle 138, and the proximal end portion 134 can have a proximal guide pin receptacle 136, much like the embodiments discussed above. The repeating internal portion 136 can have apex struts 140 and support struts 142, as described above. For example, as shown, the support struts 142 can have an “X” configuration and can be located between two transverse support struts 144. The two transverse support struts 144 can be half the normal transverse support struts such that when two repeating internal portions 136 are joined together, the two half support struts merge to form a whole transverse support strut. The proximal and distal end portions 132, 134 can also have a coupling portion that is formed from half transverse support struts 144 that can be merged with the half transverse support struts 144 of the repeating internal portion 136. In some embodiments, the repeating internal portion 136 can also have an internal guide pin receptacle 146


In some embodiments, the length of the repeating internal portion 136 can be about 10 mm. In other embodiments, the length can be between about 5 and 25 mm. In some embodiments, the repeating internal portion 136 can have support struts that form half an “X”, such that the repeating internal portions are arranged in an alternating pattern to form “X” shaped support struts. In some embodiments, the support struts are simply diagonal struts that extend across the length of the repeating internal portion.


Methods of Implantation


The methods of implantation of the various implants described herein are described in U.S. Patent Publication No. 2011/0087294, U.S. Pat. Nos. 8,425,570, 8,444,693, 8,414,648, and 8,470,004, and co-pending U.S. Provisional Application No. 61/891,326, each of which is herein incorporated by reference in its entirety for all purposes. These methods are particularly suited for use with straight implants.


The curved implant illustrated in FIG. 12 may require modifications to the method of insertion protocols. Because the implant is curved, it may not be possible or desirable to attempt to hammer or tap the implant into the bone along a straight path using a straight guide pin, a straight drill, a straight broach and the like. Instead, it may be desirable to create and form a curved insertion path that matches the curvature of the implant.


For example, the tooling used to create the curved insertion path can have a radius of curvature that matches the radius of curvature of the implant. For example, some or all of the tooling and the implant can have a matching radius of curvature. The tooling, which can include a guide pin, a tool guide, a drill bit, a broach, and impact hammer and the like can be rotatably secured by an arm with a length equal to the radius of curvature, with one end of the arm attached to a pivot and the other end used to secure the tools and/or implant.


The rotating arm can be used to drive a curved guide pin into the bone to create a curved path through the bone, such as the ilium and the sacrum. A relatively short drill bit with a lumen for receiving the guide pin can be disposed over the curved guide pin to drill out a curved pilot bore. In some embodiments, the drill bit can be secured by the pivoting arm at the end of a curved guide and can be used to drill the curved pilot bore without the insertion of the curved guide pin.


For a curved implant with a circular cross section, the curved implant can then be advanced over the curved guide pin and into the curved insertion path that is formed by the curved pilot bore. In some embodiments, the curved implant can be held by the pivoting arm and inserted into the curved insertion path without the aid of a guide pin by rotating the curved arm.


For a rectilinear implant or more broadly a noncircular implant, the curved pilot bore can be shaped using an appropriately shaped broach that matches the overall cross-sectional shape of the implant. A curved broach, or a short broach, can be advanced over the curved guide pin if present, otherwise the curved broach or short broach can be held in the pivoting arm and advanced through the pilot bore by rotation of the pivoting arm. As the broach is advanced, it shapes the pilot bore into a shape that matches the shape of the implant.


The curved implant can then be advanced over the curved guide pin and into the curved insertion path that is formed by the curved pilot bore. In some embodiments, the curved implant can be held by the pivoting arm and inserted into the curved insertion path without the aid of a guide pin by rotating the curved arm.


More generally, the implants described herein can be used to fuse any two bone segments, such as two bones that form a joint or two bones resulting from a fracture.


The terms “about” and “approximately” and the like can mean within 5, 10, 15, 20, 25, or 30 percent.


It is understood that this disclosure, in many respects, is only illustrative of the numerous alternative device embodiments of the present invention. Changes may be made in the details, particularly in matters of shape, size, material and arrangement of various device components without exceeding the scope of the various embodiments of the invention. Those skilled in the art will appreciate that the exemplary embodiments and descriptions thereof are merely illustrative of the invention as a whole. While several principles of the invention are made clear in the exemplary embodiments described above, those skilled in the art will appreciate that modifications of the structure, arrangement, proportions, elements, materials and methods of use, may be utilized in the practice of the invention, and otherwise, which are particularly adapted to specific environments and operative requirements without departing from the scope of the invention. In addition, while certain features and elements have been described in connection with particular embodiments, those skilled in the art will appreciate that those features and elements can be combined with the other embodiments disclosed herein.

Claims
  • 1. An implant for the fixation or fusion of a sacroiliac joint, the implant comprising: an elongate body having a fixed length, a proximal end, a distal end, a longitudinal axis and a rectilinear outer profile in a cross-section transverse to the longitudinal axis, the elongate body further comprising:a plurality of linear apex struts disposed between the proximal end and the distal end of the elongate body, wherein each apex strut of the plurality of linear apex struts is part of a first pair of apex struts with a first circumferentially adjacent apex strut, and is part of a second pair of apex struts with a second circumferentially adjacent apex strut, anda plurality of faces, wherein every pair of circumferentially adjacent linear apex struts has one of the plurality of faces therebetween, and wherein each of the plurality of faces includes a plurality of fenestrations, wherein the plurality of linear apex struts are preferentially porous with radially outer portions of the plurality of linear apex struts being porous and radially inner portions of the plurality of linear apex struts are not porous.
  • 2. The implant of claim 1, wherein each of the plurality of faces comprises a matrix structure.
  • 3. The implant of claim 1, wherein each of the plurality of faces comprises a matrix structure including a plurality of support struts extending between the respective pair of adjacent linear apex struts.
  • 4. The implant of claim 3, wherein the plurality of support struts comprises a plurality of transverse support struts.
  • 5. The implant of claim 3, wherein the plurality of support struts comprises a plurality of oblique support struts.
  • 6. The implant of claim 3, wherein the plurality of support struts are preferentially porous with radially outer portions of the plurality of support struts being porous and radially inner portions of the plurality of support struts not porous.
  • 7. The implant of claim 1, wherein each face includes a first set of fenestrations and a second set of fenestrations, wherein the fenestrations in the first set of fenestrations have a different size than the fenestrations in the second set of fenestrations.
  • 8. The implant of claim 7, wherein the fenestrations in the first set of fenestrations are triangular.
  • 9. An implant for the fixation or fusion of a sacroiliac joint, the implant comprising: an elongate body having a fixed length, a proximal end, a distal end, a longitudinal axis and a rectilinear outer profile in a cross-section transverse to the longitudinal axis, the elongate body further comprising:a plurality of linear apex struts parallel with the longitudinal axis and disposed between the proximal end and the distal end of the elongate body, wherein each apex strut of the plurality of linear apex struts is part of a first pair of apex struts with a first circumferentially adjacent apex strut, and is part of a second pair of apex struts with a second circumferentially adjacent apex strut; anda plurality of faces, wherein every pair of circumferentially adjacent linear apex struts has one of the plurality of faces therebetween, and wherein each of the plurality of faces includes a plurality of support struts defining a plurality of fenestrations, wherein the plurality of linear apex struts are preferentially porous with radially outer portions of the plurality of linear apex struts being porous and radially inner portions of the plurality of linear apex struts are not porous.
  • 10. The implant of claim 9, wherein the plurality of support struts in each of the plurality of faces includes at least one of a plurality of transverse support struts or a plurality of oblique support struts.
  • 11. The implant of claim 10, wherein the plurality of support struts in each of the plurality of faces consists of a plurality of transverse support struts and a plurality of oblique support struts.
  • 12. The implant of claim 9, wherein each face of the plurality of faces includes a first set of fenestrations and a second set of fenestrations, wherein the fenestrations in the first set of fenestrations have a different size than the fenestrations in the second set of fenestrations.
  • 13. The implant of claim 12, wherein the fenestrations in the first set of fenestrations are triangular.
  • 14. An implant for the fixation or fusion of a sacroiliac joint, the implant comprising: an elongate body having a fixed length, a proximal end, a distal end, a longitudinal axis and a triangular outer profile in a cross-section transverse to the longitudinal axis, the elongate body further comprising:a plurality of linear apex struts disposed between the proximal end and the distal end of the elongate body, wherein each apex strut of the plurality of linear apex struts is part of a first pair of apex struts with a first circumferentially adjacent apex strut, and is part of a second pair of apex struts with a second circumferentially adjacent apex strut; anda plurality of faces, wherein every pair of circumferentially adjacent linear apex struts has one of the plurality of faces therebetween, and wherein each of the plurality of faces includes a plurality of support struts forming a plurality of fenestrations in the corresponding face, wherein the plurality of linear apex struts are preferentially porous with radially outer portions of the plurality of linear apex struts being porous and radially inner portions of the plurality of linear apex struts are not porous, andwherein the plurality of support struts in each of the plurality of faces are preferentially porous with radially outer portions of the plurality of support struts being porous and radially inner portions of the plurality of support struts not porous.
  • 15. The implant of claim 14, wherein the plurality of support struts in each of the plurality of faces includes at least one of a plurality of transverse support struts or a plurality of oblique support struts.
  • 16. The implant of claim 15, wherein the plurality of support struts in each of the plurality of faces consists of a plurality of transverse support struts and a plurality of oblique support struts.
  • 17. The implant of claim 14, wherein each face of the plurality of faces includes a first set of fenestrations and a second set of fenestrations, wherein the fenestrations in the first set of fenestrations have a different size than the fenestrations in the second set of fenestrations.
  • 18. The implant of claim 17, wherein the fenestrations in the first set of fenestrations are triangular.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/263,971, filed Jan. 31, 2019, which is a continuation of U.S. patent application Ser. No. 15/593,208, filed May 11, 2017, now U.S. Pat. No. 10,194,962, which is a continuation of U.S. patent application Ser. No. 14/859,005, filed Sep. 18, 2015, now U.S. Pat. No. 9,662,157, which claims priority to U.S. Provisional Patent Application No. 62/052,379, filed Sep. 18, 2014, each of which is herein incorporated by reference in its entirety for all purposes.

US Referenced Citations (861)
Number Name Date Kind
1951278 Ericsson Mar 1934 A
2136471 Schneider Nov 1938 A
2243717 Moreira May 1941 A
2414882 Longfellow Jul 1947 A
2562419 Ferris Jul 1951 A
2675801 Bambara et al. Apr 1954 A
2697433 Zehnder Dec 1954 A
3076453 Tronzo Feb 1963 A
3506982 Steffee Apr 1970 A
3694821 Moritz Oct 1972 A
3709218 Halloran Jan 1973 A
3744488 Cox Jul 1973 A
4059115 Jumashev et al. Nov 1977 A
4156943 Collier Jun 1979 A
4197645 Scheicher Apr 1980 A
4292964 Ulrich Oct 1981 A
4341206 Perrett et al. Jul 1982 A
4344190 Lee et al. Aug 1982 A
4399813 Barber Aug 1983 A
4423721 Otte et al. Jan 1984 A
4475545 Ender Oct 1984 A
4501269 Bagby Feb 1985 A
4569338 Edwards Feb 1986 A
4612918 Slocum Sep 1986 A
4622959 Marcus Nov 1986 A
4630601 Harder et al. Dec 1986 A
4638799 Moore Jan 1987 A
4657550 Daher Apr 1987 A
4743256 Brantigan May 1988 A
4773402 Asher et al. Sep 1988 A
4787378 Sodhi Nov 1988 A
4790303 Steffee Dec 1988 A
4834757 Brantigan May 1989 A
4846162 Moehring Jul 1989 A
4877019 Vives Oct 1989 A
4878915 Brantigan Nov 1989 A
4898186 Ikada et al. Feb 1990 A
4904261 Dove et al. Feb 1990 A
4950270 Bowman et al. Aug 1990 A
4961740 Ray et al. Oct 1990 A
4969888 Scholten et al. Nov 1990 A
4981481 Kranz et al. Jan 1991 A
5034011 Howland Jul 1991 A
5034013 Kyle et al. Jul 1991 A
5035697 Frigg Jul 1991 A
5041118 Wasilewski Aug 1991 A
5053035 McLaren Oct 1991 A
5059193 Kuslich Oct 1991 A
5066296 Chapman et al. Nov 1991 A
5098434 Serbousek Mar 1992 A
5102414 Kirsch Apr 1992 A
5108397 White Apr 1992 A
5122141 Simpson et al. Jun 1992 A
5139498 Astudillo Ley Aug 1992 A
5139500 Schwartz Aug 1992 A
5147367 Ellis Sep 1992 A
5147402 Bohler et al. Sep 1992 A
5190551 Chin et al. Mar 1993 A
5197961 Castle Mar 1993 A
5242444 MacMillan Sep 1993 A
5298254 Prewett et al. Mar 1994 A
5334205 Cain Aug 1994 A
5380325 Lahille et al. Jan 1995 A
5390683 Pisharodi Feb 1995 A
5433718 Brinker Jul 1995 A
5443466 Shah Aug 1995 A
5458638 Kuslich et al. Oct 1995 A
5470334 Ross et al. Nov 1995 A
5480402 Kim Jan 1996 A
5569249 James et al. Oct 1996 A
5591235 Kuslich Jan 1997 A
5593409 Michelson Jan 1997 A
5607424 Tropiano Mar 1997 A
5609635 Michelson Mar 1997 A
5609636 Kohrs et al. Mar 1997 A
5626616 Speece May 1997 A
5643264 Sherman et al. Jul 1997 A
5645599 Samani Jul 1997 A
5658337 Kohrs et al. Aug 1997 A
5667510 Combs Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5672178 Petersen Sep 1997 A
5683391 Boyd Nov 1997 A
5709683 Bagby Jan 1998 A
5713904 Errico et al. Feb 1998 A
5716358 Ochoa et al. Feb 1998 A
5725581 Brånemark Mar 1998 A
5743912 LaHille et al. Apr 1998 A
5759035 Ricci Jun 1998 A
5766174 Perry Jun 1998 A
5766252 Henry et al. Jun 1998 A
5766261 Neal et al. Jun 1998 A
5788699 Bobst et al. Aug 1998 A
5800440 Stead Sep 1998 A
5868749 Reed Feb 1999 A
5897556 Drewry et al. Apr 1999 A
5928239 Mirza Jul 1999 A
5941885 Jackson Aug 1999 A
5961522 Mehdizadeh Oct 1999 A
5961554 Janson et al. Oct 1999 A
6010507 Rudloff Jan 2000 A
6015409 Jackson Jan 2000 A
6030162 Huebner et al. Feb 2000 A
6053916 Moore Apr 2000 A
6056749 Kuslich May 2000 A
6066175 Henderson et al. May 2000 A
6086589 Kuslich et al. Jul 2000 A
6096080 Nicholson et al. Aug 2000 A
6120292 Buser et al. Sep 2000 A
6120504 Brumback et al. Sep 2000 A
6143031 Knothe et al. Nov 2000 A
6197062 Fenlin Mar 2001 B1
6206924 Timm Mar 2001 B1
6210442 Wing et al. Apr 2001 B1
6214049 Gayer et al. Apr 2001 B1
6221074 Cole et al. Apr 2001 B1
6224607 Michelson May 2001 B1
6241732 Overaker et al. Jun 2001 B1
6264657 Urbahns et al. Jul 2001 B1
6270528 McKay Aug 2001 B1
6287343 Kuslich et al. Sep 2001 B1
6302885 Essiger Oct 2001 B1
6302914 Michelson Oct 2001 B1
6306140 Siddiqui Oct 2001 B1
6319253 Ackeret et al. Nov 2001 B1
6406498 Tormala et al. Jun 2002 B1
6409768 Tepic et al. Jun 2002 B1
6436139 Shapiro et al. Aug 2002 B1
6451020 Zucherman et al. Sep 2002 B1
6471707 Miller et al. Oct 2002 B1
6485518 Cornwall et al. Nov 2002 B1
6497707 Bowman et al. Dec 2002 B1
6517541 Sesic Feb 2003 B1
6520969 Lambrecht et al. Feb 2003 B2
6524314 Dean et al. Feb 2003 B1
6527775 Warburton Mar 2003 B1
6551343 Törmälii et al. Apr 2003 B1
6556857 Estes et al. Apr 2003 B1
6558386 Cragg May 2003 B1
6565566 Wagner et al. May 2003 B1
6575899 Foley et al. Jun 2003 B1
6575991 Chesbrough et al. Jun 2003 B1
6579293 Chandran Jun 2003 B1
6582431 Ray Jun 2003 B1
6582467 Teitelbaum et al. Jun 2003 B1
6595998 Johnson et al. Jul 2003 B2
6602293 Biermann et al. Aug 2003 B1
6605090 Trieu et al. Aug 2003 B1
6607530 Carl et al. Aug 2003 B1
6620163 Michelson Sep 2003 B1
6635059 Randall et al. Oct 2003 B2
6666868 Fallin Dec 2003 B2
6669529 Scaries Dec 2003 B1
6673075 Santilli Jan 2004 B2
6692501 Michelson Feb 2004 B2
6712852 Chung et al. Mar 2004 B1
6723099 Goshert Apr 2004 B1
6723100 Biedermann et al. Apr 2004 B2
6740118 Eisermann et al. May 2004 B2
6743257 Castro Jun 2004 B2
D493533 Blain Jul 2004 S
6793656 Mathews Sep 2004 B1
6827740 Michelson Dec 2004 B1
6984235 Huebner Jan 2006 B2
6989033 Schmidt Jan 2006 B1
6991461 Gittleman Jan 2006 B2
6993406 Cesarano et al. Jan 2006 B1
7018416 Hanson et al. Mar 2006 B2
7118579 Michelson Oct 2006 B2
7147666 Grisoni Dec 2006 B1
7175663 Stone Feb 2007 B1
7211085 Michelson May 2007 B2
7223269 Chappuis May 2007 B2
7314488 Reiley Jan 2008 B2
7335205 Aeschlimann et al. Feb 2008 B2
7338500 Chappuis Mar 2008 B2
7396365 Michelson Jul 2008 B2
7452359 Michelson Nov 2008 B1
7452369 Barry Nov 2008 B2
7481831 Bonutti Jan 2009 B2
7527649 Blain May 2009 B1
7534254 Michelson May 2009 B1
7537616 Branch May 2009 B1
7569054 Michelson Aug 2009 B2
7569059 Cerundolo Aug 2009 B2
7601155 Petersen Oct 2009 B2
7608097 Kyle Oct 2009 B2
7608098 Stone et al. Oct 2009 B1
7648509 Stark Jan 2010 B2
7686805 Michelson Mar 2010 B2
7699852 Frankel et al. Apr 2010 B2
7708761 Petersen May 2010 B2
7727235 Contiliano et al. Jun 2010 B2
7758646 Khandkar et al. Jul 2010 B2
7780704 Markworth et al. Aug 2010 B2
7846162 Nelson et al. Dec 2010 B2
7850732 Heinz Dec 2010 B2
7857832 Culbert et al. Dec 2010 B2
7887565 Michelson Feb 2011 B2
7892265 Perez-Cruet et al. Feb 2011 B2
7901439 Horton Mar 2011 B2
7909832 Michelson Mar 2011 B2
7922765 Reiley Apr 2011 B2
7942879 Christie et al. May 2011 B2
7951176 Grady et al. May 2011 B2
8052728 Hestad Nov 2011 B2
8062365 Schwab Nov 2011 B2
8066705 Michelson Nov 2011 B2
8066709 Michelson Nov 2011 B2
8092505 Sommers Jan 2012 B2
8142481 Warnick Mar 2012 B2
8202305 Reiley Jun 2012 B2
8221499 Lazzara et al. Jul 2012 B2
8257398 Jackson Sep 2012 B2
8268099 O'Neill et al. Sep 2012 B2
8308779 Reiley Nov 2012 B2
8308783 Morris et al. Nov 2012 B2
8317862 Troger et al. Nov 2012 B2
8348950 Assell et al. Jan 2013 B2
8350186 Jones et al. Jan 2013 B2
8388667 Reiley et al. Mar 2013 B2
8394129 Morgenstern Lopez Mar 2013 B2
8398635 Vaidya Mar 2013 B2
8398682 Jackson et al. Mar 2013 B2
8414648 Reiley Apr 2013 B2
8425570 Reiley Apr 2013 B2
8430930 Hunt Apr 2013 B2
8444693 Reiley May 2013 B2
8449585 Wallenstein et al. May 2013 B2
8467851 Mire et al. Jun 2013 B2
8470004 Reiley Jun 2013 B2
8475505 Nebosky et al. Jul 2013 B2
8529608 Terrill et al. Sep 2013 B2
8597299 Farr et al. Dec 2013 B2
8608802 Bagga et al. Dec 2013 B2
D697209 Walthall et al. Jan 2014 S
8641737 Matthis et al. Feb 2014 B2
8663332 To et al. Mar 2014 B1
8672986 Klaue et al. Mar 2014 B2
8734462 Reiley et al. May 2014 B2
8778026 Mauldin Jul 2014 B2
8840623 Reiley Sep 2014 B2
8840651 Reiley Sep 2014 B2
8845693 Smith et al. Sep 2014 B2
8858601 Reiley Oct 2014 B2
8888827 Harper et al. Nov 2014 B2
8894685 Mickiewicz et al. Nov 2014 B2
8920477 Reiley Dec 2014 B2
8926670 Jackson Jan 2015 B2
8936623 Jackson Jan 2015 B2
8945190 Culbert et al. Feb 2015 B2
8945193 Kirschman Feb 2015 B2
8951254 Mayer et al. Feb 2015 B2
8951293 Glazer et al. Feb 2015 B2
8951295 Matityahu et al. Feb 2015 B2
8961571 Lee et al. Feb 2015 B2
8979911 Martineau et al. Mar 2015 B2
8986348 Reiley Mar 2015 B2
RE45484 Foley et al. Apr 2015 E
9039743 Reiley May 2015 B2
9044321 Mauldin et al. Jun 2015 B2
9060876 To et al. Jun 2015 B1
9089371 Faulhaber Jul 2015 B1
D738498 Frey et al. Sep 2015 S
9131955 Swofford Sep 2015 B2
9149286 Greenhalgh et al. Oct 2015 B1
9198676 Pilgeram et al. Dec 2015 B2
9220535 Röbling et al. Dec 2015 B2
9314286 Bottlang et al. Apr 2016 B2
9314348 Emstad Apr 2016 B2
9358047 Mishra et al. Jun 2016 B2
9358057 Whipple et al. Jun 2016 B1
9375243 Vestgaarden Jun 2016 B1
9375323 Reiley Jun 2016 B2
9445852 Sweeney Sep 2016 B2
9451999 Simpson et al. Sep 2016 B2
9452065 Lawson Sep 2016 B1
9486264 Reiley et al. Nov 2016 B2
9492201 Reiley Nov 2016 B2
9498264 Harshman et al. Nov 2016 B2
9510872 Donner et al. Dec 2016 B2
9517095 Vaidya Dec 2016 B2
9526548 Asfora Dec 2016 B2
9554909 Donner Jan 2017 B2
9561063 Reiley Feb 2017 B2
9566100 Asfora Feb 2017 B2
9603613 Schoenefeld et al. Mar 2017 B2
9603644 Sweeney Mar 2017 B2
D783821 Folsom et al. Apr 2017 S
9615856 Amett et al. Apr 2017 B2
9622783 Reiley et al. Apr 2017 B2
9655656 Whipple May 2017 B2
9662124 Assell et al. May 2017 B2
9662128 Reiley May 2017 B2
9662157 Schneider et al. May 2017 B2
9662158 Reiley May 2017 B2
9675394 Reiley Jun 2017 B2
9743969 Reiley Aug 2017 B2
9757154 Donner et al. Sep 2017 B2
9763695 Mirda Sep 2017 B2
9763802 Baynham Sep 2017 B2
9775648 Greenberg et al. Oct 2017 B2
9788961 Donner et al. Oct 2017 B2
9808298 Stroncek et al. Nov 2017 B2
9808299 Goel et al. Nov 2017 B2
9808337 Housman et al. Nov 2017 B2
9820789 Reiley Nov 2017 B2
9826986 Donner et al. Nov 2017 B2
9839448 Reckling et al. Dec 2017 B2
9848889 Taylor et al. Dec 2017 B2
9848892 Biedermann et al. Dec 2017 B2
9883874 Vestgaarden Feb 2018 B1
9888911 Siegal Feb 2018 B2
9936983 Mesiwala et al. Apr 2018 B2
9949776 Mobasser et al. Apr 2018 B2
9949843 Reiley et al. Apr 2018 B2
9956013 Reiley et al. May 2018 B2
9993276 Russell Jun 2018 B2
9993277 Krinke et al. Jun 2018 B2
9999449 Bonutti Jun 2018 B2
10004547 Reiley Jun 2018 B2
10034676 Donner Jul 2018 B2
10058430 Donner et al. Aug 2018 B2
10064670 Mootien et al. Sep 2018 B2
10166022 Early et al. Jan 2019 B2
10166033 Reiley et al. Jan 2019 B2
10179014 Menmuir et al. Jan 2019 B1
10188403 Mirochinik et al. Jan 2019 B2
10194951 Jackson et al. Feb 2019 B2
10194962 Schneider et al. Feb 2019 B2
10201427 Mauldin et al. Feb 2019 B2
10219885 Mamo et al. Mar 2019 B2
10245044 Petersen Apr 2019 B2
10245076 Fitzpatrick Apr 2019 B2
10245087 Donner et al. Apr 2019 B2
10258380 Sinha Apr 2019 B2
10258393 Caploon et al. Apr 2019 B2
10258394 Harshman et al. Apr 2019 B2
10271882 Biedermann et al. Apr 2019 B2
10278737 Smith May 2019 B2
10292778 Kostrzewski et al. May 2019 B2
10314631 Gonzalez Blohm et al. Jun 2019 B2
10321937 Cormier et al. Jun 2019 B2
10321945 Schifano et al. Jun 2019 B2
10335202 Ziolo et al. Jul 2019 B2
10335204 Matthis et al. Jul 2019 B2
10335206 Nichols et al. Jul 2019 B2
10335211 Chan et al. Jul 2019 B2
10335212 Paolino et al. Jul 2019 B2
10335216 Mari et al. Jul 2019 B2
10342586 Schneider Jul 2019 B2
10349983 Purcell et al. Jul 2019 B2
10357287 Schlaepfer et al. Jul 2019 B2
10363070 Jackson et al. Jul 2019 B2
10363140 Mauldin et al. Jul 2019 B2
10363143 Neubardt Jul 2019 B2
10368919 Pham et al. Aug 2019 B2
10426533 Mauldin et al. Oct 2019 B2
10426539 Schifano et al. Oct 2019 B2
10433880 Donner et al. Oct 2019 B2
10478227 Leff et al. Nov 2019 B2
10492841 Hartdegen et al. Dec 2019 B2
10492921 McShane, III Dec 2019 B2
10517734 Donner Dec 2019 B2
10531898 Boulot Jan 2020 B2
10531904 Kolb Jan 2020 B2
10537340 Mirochinik et al. Jan 2020 B2
10555758 Magee et al. Feb 2020 B2
10588676 Kang et al. Mar 2020 B2
10588677 McDonnell Mar 2020 B2
10596003 Donner et al. Mar 2020 B2
10603087 Brenzel et al. Mar 2020 B2
10610275 Brianza Apr 2020 B2
10610370 Baynham Apr 2020 B2
10617453 Beckett et al. Apr 2020 B2
10653454 Frey et al. May 2020 B2
10653544 Forsell May 2020 B2
10660679 Kang et al. May 2020 B2
10660684 Kang et al. May 2020 B2
10682150 Stark Jun 2020 B2
10682437 Roth Jun 2020 B2
10709570 Stauffer Jul 2020 B2
10711334 Patel et al. Jul 2020 B2
10729475 Childs Aug 2020 B2
10729482 Fantigrossi et al. Aug 2020 B2
10743995 Fallin et al. Aug 2020 B2
10792074 Jackson Oct 2020 B2
10799277 Kulper et al. Oct 2020 B2
10799367 Vrionis et al. Oct 2020 B2
10842634 Pasini et al. Nov 2020 B2
D905232 Schifano et al. Dec 2020 S
10898333 Cordaro Jan 2021 B2
10932838 Mehl et al. Mar 2021 B2
10959758 Mesiwala et al. Mar 2021 B2
10993757 Schifano et al. May 2021 B2
11006985 Caploon et al. May 2021 B2
D922568 Schifano et al. Jun 2021 S
11071573 Schneider Jul 2021 B2
11116519 Sand et al. Sep 2021 B2
11147591 Jackson Oct 2021 B2
11147597 Jackson Oct 2021 B2
11147688 Reckling et al. Oct 2021 B2
11172939 Donner et al. Nov 2021 B2
11266767 Roth et al. Mar 2022 B2
11284798 Donner et al. Mar 2022 B2
11284887 Hartdegen et al. Mar 2022 B2
D951455 Ginn May 2022 S
D972137 Schifano et al. Dec 2022 S
11607251 Albert et al. Mar 2023 B2
11607256 Folsom et al. Mar 2023 B1
11850156 Mauldin et al. Dec 2023 B2
20010012942 Estes et al. Aug 2001 A1
20010046518 Sawhney Nov 2001 A1
20010047207 Michelson Nov 2001 A1
20010049529 Cachia et al. Dec 2001 A1
20020019637 Frey et al. Feb 2002 A1
20020029043 Ahrens et al. Mar 2002 A1
20020038123 Visotsky et al. Mar 2002 A1
20020049497 Mason Apr 2002 A1
20020077641 Michelson Jun 2002 A1
20020082598 Teitelbaum Jun 2002 A1
20020120275 Schmieding et al. Aug 2002 A1
20020120335 Angelucci et al. Aug 2002 A1
20020128652 Ferree Sep 2002 A1
20020143334 von Hoffmann et al. Oct 2002 A1
20020143335 von Hoffmann et al. Oct 2002 A1
20020151903 Takei et al. Oct 2002 A1
20020169507 Malone Nov 2002 A1
20020183858 Contiliano et al. Dec 2002 A1
20020198527 Mückter Dec 2002 A1
20030018336 Vandewalle Jan 2003 A1
20030032961 Pelo et al. Feb 2003 A1
20030050642 Schmieding et al. Mar 2003 A1
20030065332 TenHuisen et al. Apr 2003 A1
20030074000 Roth et al. Apr 2003 A1
20030078660 Clifford et al. Apr 2003 A1
20030083668 Rogers et al. May 2003 A1
20030083688 Simonson May 2003 A1
20030088251 Braun et al. May 2003 A1
20030097131 Schon et al. May 2003 A1
20030139815 Grooms et al. Jul 2003 A1
20030181979 Ferree Sep 2003 A1
20030181982 Kuslich Sep 2003 A1
20030199983 Michelson Oct 2003 A1
20030229358 Errico et al. Dec 2003 A1
20030233146 Grinberg et al. Dec 2003 A1
20030233147 Nicholson et al. Dec 2003 A1
20040010315 Song Jan 2004 A1
20040024458 Senegas et al. Feb 2004 A1
20040034422 Errico et al. Feb 2004 A1
20040073216 Lieberman Apr 2004 A1
20040073314 White et al. Apr 2004 A1
20040082955 Zirkle Apr 2004 A1
20040087948 Suddaby May 2004 A1
20040097927 Yeung et al. May 2004 A1
20040106925 Culbert Jun 2004 A1
20040117022 Marnay et al. Jun 2004 A1
20040127990 Bartish, Jr. et al. Jul 2004 A1
20040138750 Mitchell Jul 2004 A1
20040138753 Ferree Jul 2004 A1
20040147929 Biedermann et al. Jul 2004 A1
20040158324 Lange Aug 2004 A1
20040176287 Harrison et al. Sep 2004 A1
20040176853 Sennett et al. Sep 2004 A1
20040181282 Zucherman et al. Sep 2004 A1
20040186572 Lange et al. Sep 2004 A1
20040210221 Kozak et al. Oct 2004 A1
20040225360 Malone Nov 2004 A1
20040230305 Gorensek et al. Nov 2004 A1
20040260286 Ferree Dec 2004 A1
20040267369 Lyons et al. Dec 2004 A1
20050015059 Sweeney Jan 2005 A1
20050015146 Louis et al. Jan 2005 A1
20050033435 Belliard et al. Feb 2005 A1
20050037319 Bulard et al. Feb 2005 A1
20050049590 Alleyne et al. Mar 2005 A1
20050055023 Sohngen et al. Mar 2005 A1
20050070905 Donnelly et al. Mar 2005 A1
20050071004 Re et al. Mar 2005 A1
20050075641 Singhatat et al. Apr 2005 A1
20050080415 Keyer et al. Apr 2005 A1
20050107878 Conchy May 2005 A1
20050112397 Rolfe et al. May 2005 A1
20050113919 Cragg et al. May 2005 A1
20050124993 Chappuis Jun 2005 A1
20050131409 Chervitz et al. Jun 2005 A1
20050137605 Assell et al. Jun 2005 A1
20050143837 Ferree Jun 2005 A1
20050149192 Zucherman et al. Jul 2005 A1
20050159749 Levy et al. Jul 2005 A1
20050159812 Dinger et al. Jul 2005 A1
20050165398 Reiley Jul 2005 A1
20050192572 Abdelgany et al. Sep 2005 A1
20050216082 Wilson et al. Sep 2005 A1
20050228384 Zucherman et al. Oct 2005 A1
20050246021 Ringeisen et al. Nov 2005 A1
20050251146 Martz et al. Nov 2005 A1
20050273101 Schumacher Dec 2005 A1
20050277940 Neff Dec 2005 A1
20060004396 Easley et al. Jan 2006 A1
20060025771 Jackson Feb 2006 A1
20060036247 Michelson Feb 2006 A1
20060036251 Reiley Feb 2006 A1
20060036252 Baynham et al. Feb 2006 A1
20060036322 Reiley Feb 2006 A1
20060054171 Dall Mar 2006 A1
20060058793 Michelson Mar 2006 A1
20060058800 Ainsworth et al. Mar 2006 A1
20060062825 Maccecchini Mar 2006 A1
20060084986 Grinberg et al. Apr 2006 A1
20060089644 Felix Apr 2006 A1
20060089656 Allard et al. Apr 2006 A1
20060095038 Jackson May 2006 A1
20060111779 Petersen May 2006 A1
20060129247 Brown et al. Jun 2006 A1
20060142772 Ralph et al. Jun 2006 A1
20060161163 Shino Jul 2006 A1
20060178673 Curran Aug 2006 A1
20060195094 McGraw et al. Aug 2006 A1
20060217717 Whipple Sep 2006 A1
20060241600 Ensign et al. Oct 2006 A1
20060241776 Brown et al. Oct 2006 A1
20060271054 Sucec et al. Nov 2006 A1
20060293662 Boyer, II et al. Dec 2006 A1
20070027544 McCord et al. Feb 2007 A1
20070038219 Matthis et al. Feb 2007 A1
20070049933 Ahn et al. Mar 2007 A1
20070066977 Assell et al. Mar 2007 A1
20070083265 Malone Apr 2007 A1
20070088362 Bonutti et al. Apr 2007 A1
20070093841 Hoogland Apr 2007 A1
20070093898 Schwab et al. Apr 2007 A1
20070106383 Abdou May 2007 A1
20070149976 Hale et al. Jun 2007 A1
20070156144 Ulrich et al. Jul 2007 A1
20070156241 Reiley et al. Jul 2007 A1
20070156246 Meswania et al. Jul 2007 A1
20070161985 Demakas et al. Jul 2007 A1
20070161989 Heinz et al. Jul 2007 A1
20070173820 Trieu Jul 2007 A1
20070219634 Greenhalgh et al. Sep 2007 A1
20070233080 Na et al. Oct 2007 A1
20070233146 Henniges et al. Oct 2007 A1
20070233247 Schwab Oct 2007 A1
20070250166 McKay Oct 2007 A1
20070270833 Bonutti et al. Nov 2007 A1
20070270879 Isaza et al. Nov 2007 A1
20070282443 Globerman et al. Dec 2007 A1
20080021454 Chao et al. Jan 2008 A1
20080021455 Chao et al. Jan 2008 A1
20080021456 Gupta et al. Jan 2008 A1
20080021461 Barker et al. Jan 2008 A1
20080021480 Chin et al. Jan 2008 A1
20080065093 Assell et al. Mar 2008 A1
20080065215 Reiley Mar 2008 A1
20080071356 Greenhalgh et al. Mar 2008 A1
20080109083 Van Hoeck et al. May 2008 A1
20080125868 Branemark et al. May 2008 A1
20080132901 Recoules-Arche et al. Jun 2008 A1
20080140082 Erdem et al. Jun 2008 A1
20080147079 Chin et al. Jun 2008 A1
20080154314 McDevitt Jun 2008 A1
20080154374 Labrom Jun 2008 A1
20080161810 Melkent Jul 2008 A1
20080161927 Savage Jul 2008 A1
20080183204 Greenhalgh et al. Jul 2008 A1
20080234758 Fisher et al. Sep 2008 A1
20080255562 Gil et al. Oct 2008 A1
20080255618 Fisher et al. Oct 2008 A1
20080255622 Mickiewicz et al. Oct 2008 A1
20080255664 Hogendijk et al. Oct 2008 A1
20080255666 Fisher et al. Oct 2008 A1
20080255667 Horton Oct 2008 A1
20080275454 Geibel Nov 2008 A1
20080294202 Peterson et al. Nov 2008 A1
20080306554 McKinley Dec 2008 A1
20090012529 Blain et al. Jan 2009 A1
20090018660 Roush Jan 2009 A1
20090024174 Stark Jan 2009 A1
20090036927 Vestgaarden Feb 2009 A1
20090037148 Lin et al. Feb 2009 A1
20090043393 Duggal et al. Feb 2009 A1
20090082810 Bhatnagar et al. Mar 2009 A1
20090082869 Slemker et al. Mar 2009 A1
20090099602 Aflatoon Apr 2009 A1
20090099610 Johnson et al. Apr 2009 A1
20090105770 Berrevooets et al. Apr 2009 A1
20090118771 Gonzalez-Hernandez May 2009 A1
20090131986 Lee et al. May 2009 A1
20090138053 Assell et al. May 2009 A1
20090157119 Hale Jun 2009 A1
20090163920 Hochschuler et al. Jun 2009 A1
20090171394 Adbou Jul 2009 A1
20090187247 Metcalf, Jr. et al. Jul 2009 A1
20090216238 Stark Aug 2009 A1
20090270929 Suddaby Oct 2009 A1
20090287254 Nayet et al. Nov 2009 A1
20090312798 Varela Dec 2009 A1
20090319043 McDevitt et al. Dec 2009 A1
20090324678 Thome et al. Dec 2009 A1
20100003638 Collins et al. Jan 2010 A1
20100022535 Lee et al. Jan 2010 A1
20100076502 Guyer et al. Mar 2010 A1
20100081107 Bagambisa et al. Apr 2010 A1
20100094290 Vaidya Apr 2010 A1
20100094295 Schnieders et al. Apr 2010 A1
20100094420 Grohowski Apr 2010 A1
20100106194 Bonutti et al. Apr 2010 A1
20100106195 Serhan et al. Apr 2010 A1
20100114174 Jones et al. May 2010 A1
20100114317 Lambrecht et al. May 2010 A1
20100131011 Stark May 2010 A1
20100137990 Apatsidis et al. Jun 2010 A1
20100145461 Landry et al. Jun 2010 A1
20100160977 Gephart et al. Jun 2010 A1
20100161061 Hunt Jun 2010 A1
20100168798 Clineff et al. Jul 2010 A1
20100191292 DeMeo et al. Jul 2010 A1
20100262242 Chavatte et al. Oct 2010 A1
20100268228 Petersen Oct 2010 A1
20100280619 Yuan et al. Nov 2010 A1
20100280622 McKinley Nov 2010 A1
20100286778 Eisermann et al. Nov 2010 A1
20100331851 Huene Dec 2010 A1
20100331893 Geist et al. Dec 2010 A1
20110009869 Marino et al. Jan 2011 A1
20110009966 Michelson Jan 2011 A1
20110022089 Assell et al. Jan 2011 A1
20110029019 Ainsworth et al. Feb 2011 A1
20110040362 Godara et al. Feb 2011 A1
20110046737 Teisen Feb 2011 A1
20110060373 Russell et al. Mar 2011 A1
20110060375 Bonutti Mar 2011 A1
20110066190 Schaller et al. Mar 2011 A1
20110082551 Kraus Apr 2011 A1
20110093020 Wu Apr 2011 A1
20110098747 Donner et al. Apr 2011 A1
20110098816 Jacob et al. Apr 2011 A1
20110098817 Eckhardt et al. Apr 2011 A1
20110106175 Rezach May 2011 A1
20110153018 Walters et al. Jun 2011 A1
20110160866 Laurence et al. Jun 2011 A1
20110178561 Roh Jul 2011 A1
20110184417 Kitch et al. Jul 2011 A1
20110184518 Trieu Jul 2011 A1
20110184519 Trieu Jul 2011 A1
20110184520 Trieu Jul 2011 A1
20110196372 Murase Aug 2011 A1
20110213432 Geist et al. Sep 2011 A1
20110230966 Trieu Sep 2011 A1
20110238074 Ek Sep 2011 A1
20110238124 Richelsoph Sep 2011 A1
20110238181 Trieu Sep 2011 A1
20110245930 Alley et al. Oct 2011 A1
20110257755 Bellemere et al. Oct 2011 A1
20110264229 Donner Oct 2011 A1
20110276098 Biedermann et al. Nov 2011 A1
20110295272 Assell et al. Dec 2011 A1
20110295370 Suh et al. Dec 2011 A1
20110313471 McLean et al. Dec 2011 A1
20110313532 Hunt Dec 2011 A1
20110319995 Voellmicke et al. Dec 2011 A1
20120004730 Castro Jan 2012 A1
20120035667 Van Nortwick et al. Feb 2012 A1
20120083887 Purcell et al. Apr 2012 A1
20120095560 Donner Apr 2012 A1
20120179256 Reiley Jul 2012 A1
20120191191 Trieu Jul 2012 A1
20120215315 Hochschuler et al. Aug 2012 A1
20120226318 Wenger et al. Sep 2012 A1
20120253398 Metcalf et al. Oct 2012 A1
20120259372 Glazer et al. Oct 2012 A1
20120271424 Crawford Oct 2012 A1
20120277866 Kalluri et al. Nov 2012 A1
20120296428 Donner Nov 2012 A1
20120323285 Assell et al. Dec 2012 A1
20130018427 Pham et al. Jan 2013 A1
20130030456 Assell et al. Jan 2013 A1
20130030529 Hunt Jan 2013 A1
20130035727 Datta Feb 2013 A1
20130053852 Greenhalgh et al. Feb 2013 A1
20130053854 Schoenefeld et al. Feb 2013 A1
20130053902 Trudeau Feb 2013 A1
20130053963 Davenport Feb 2013 A1
20130072984 Robinson Mar 2013 A1
20130085535 Greenhalgh et al. Apr 2013 A1
20130096683 Kube Apr 2013 A1
20130116793 Kloss May 2013 A1
20130123850 Schoenefeld et al. May 2013 A1
20130123935 Hunt May 2013 A1
20130131678 Dahners May 2013 A1
20130144343 Arnett et al. Jun 2013 A1
20130158609 Mikhail et al. Jun 2013 A1
20130172736 Abdou Jul 2013 A1
20130197590 Assell et al. Aug 2013 A1
20130203088 Baerlecken et al. Aug 2013 A1
20130218215 Ginn et al. Aug 2013 A1
20130218282 Hunt Aug 2013 A1
20130231746 Ginn et al. Sep 2013 A1
20130237988 Mauldin Sep 2013 A1
20130245703 Warren et al. Sep 2013 A1
20130245763 Mauldin Sep 2013 A1
20130267836 Mauldin et al. Oct 2013 A1
20130267961 Mauldin et al. Oct 2013 A1
20130267989 Mauldin et al. Oct 2013 A1
20130274890 McKay Oct 2013 A1
20130325129 Huang Dec 2013 A1
20140012334 Armstrong et al. Jan 2014 A1
20140012340 Beck et al. Jan 2014 A1
20140012384 Kana et al. Jan 2014 A1
20140031934 Trieu Jan 2014 A1
20140031935 Donner et al. Jan 2014 A1
20140031938 Lechmann et al. Jan 2014 A1
20140031939 Wolfe et al. Jan 2014 A1
20140046380 Asfora Feb 2014 A1
20140074175 Ehler et al. Mar 2014 A1
20140088596 Assell et al. Mar 2014 A1
20140088707 Donner et al. Mar 2014 A1
20140121776 Hunt May 2014 A1
20140135927 Pavlov et al. May 2014 A1
20140142700 Donner et al. May 2014 A1
20140172027 Biedermann et al. Jun 2014 A1
20140200618 Donner et al. Jul 2014 A1
20140207240 Stoffman et al. Jul 2014 A1
20140257294 Gedet et al. Sep 2014 A1
20140257408 Trieu et al. Sep 2014 A1
20140276846 Mauldin et al. Sep 2014 A1
20140276851 Schneider et al. Sep 2014 A1
20140277139 Vrionis et al. Sep 2014 A1
20140277165 Katzman et al. Sep 2014 A1
20140277460 Schifano et al. Sep 2014 A1
20140277462 Yerby et al. Sep 2014 A1
20140277463 Yerby et al. Sep 2014 A1
20140288649 Hunt Sep 2014 A1
20140288650 Hunt Sep 2014 A1
20140296982 Cheng Oct 2014 A1
20140330382 Mauldin Nov 2014 A1
20140364917 Sandstrom et al. Dec 2014 A1
20150012051 Warren et al. Jan 2015 A1
20150039037 Donner et al. Feb 2015 A1
20150080951 Yeh Mar 2015 A1
20150080972 Chin et al. Mar 2015 A1
20150094765 Donner et al. Apr 2015 A1
20150112444 Aksu Apr 2015 A1
20150147397 Altschuler May 2015 A1
20150150683 Donner et al. Jun 2015 A1
20150173805 Donner et al. Jun 2015 A1
20150173904 Stark Jun 2015 A1
20150182268 Donner et al. Jul 2015 A1
20150190149 Assell et al. Jul 2015 A1
20150190187 Parent et al. Jul 2015 A1
20150209094 Anderson Jul 2015 A1
20150216566 Mikhail et al. Aug 2015 A1
20150238203 Asfora Aug 2015 A1
20150250513 De Lavigne Sainte Sep 2015 A1
20150250611 Schifano et al. Sep 2015 A1
20150250612 Schifano et al. Sep 2015 A1
20150257892 Lechmann et al. Sep 2015 A1
20150282933 Hunt Oct 2015 A1
20150313720 Lorio Nov 2015 A1
20150320450 Mootien et al. Nov 2015 A1
20150320451 Mootien et al. Nov 2015 A1
20150320469 Biedermann et al. Nov 2015 A1
20150342753 Donner et al. Dec 2015 A1
20160000488 Cross, III Jan 2016 A1
20160022429 Greenhalgh et al. Jan 2016 A1
20160095711 Castro Apr 2016 A1
20160095721 Schell et al. Apr 2016 A1
20160100870 Lavigne et al. Apr 2016 A1
20160106477 Hynes et al. Apr 2016 A1
20160106479 Hynes et al. Apr 2016 A1
20160120661 Schell et al. May 2016 A1
20160143671 Jimenez May 2016 A1
20160016630 Papangelou et al. Jun 2016 A1
20160157908 Cawley et al. Jun 2016 A1
20160166301 Papangelou et al. Jun 2016 A1
20160175113 Lins Jun 2016 A1
20160184103 Fonte et al. Jun 2016 A1
20160213487 Wilson et al. Jul 2016 A1
20160242820 Whipple et al. Aug 2016 A1
20160242912 Lindsey et al. Aug 2016 A1
20160249940 Stark Sep 2016 A1
20160287171 Sand et al. Oct 2016 A1
20160287301 Mehl et al. Oct 2016 A1
20160310188 Marino et al. Oct 2016 A1
20160310197 Black et al. Oct 2016 A1
20160324643 Donner et al. Nov 2016 A1
20160324656 Morris et al. Nov 2016 A1
20160374727 Greenhalgh et al. Dec 2016 A1
20170014235 Jones et al. Jan 2017 A1
20170020573 Cain et al. Jan 2017 A1
20170020585 Harshman et al. Jan 2017 A1
20170049488 Vestgaarden Feb 2017 A1
20170128214 Mayer May 2017 A1
20170135733 Donner et al. May 2017 A1
20170135737 Krause May 2017 A1
20170143513 Sandstrom et al. May 2017 A1
20170202511 Chang et al. Jul 2017 A1
20170209155 Petersen Jul 2017 A1
20170216036 Cordaro Aug 2017 A1
20170224393 Lavigne et al. Aug 2017 A1
20170246000 Pavlov et al. Aug 2017 A1
20170258606 Afzal Sep 2017 A1
20170266007 Gelaude et al. Sep 2017 A1
20180036041 Pham et al. Feb 2018 A1
20180042652 Mari et al. Feb 2018 A1
20180042735 Schell et al. Feb 2018 A1
20180228617 Srour et al. Aug 2018 A1
20180228621 Reiley et al. Aug 2018 A1
20180235643 Lins et al. Aug 2018 A1
20180256232 Russell Sep 2018 A1
20180256351 Bishop Sep 2018 A1
20180296227 Meek et al. Oct 2018 A1
20180296347 Hamzey et al. Oct 2018 A1
20180360512 Mari Dec 2018 A1
20190133613 Reiley et al. May 2019 A1
20190151113 Sack May 2019 A1
20190159901 Mauldin et al. May 2019 A1
20190247094 Yacoub et al. Aug 2019 A1
20190298528 Lindsey et al. Oct 2019 A1
20190298542 Kloss Oct 2019 A1
20190343640 Donner et al. Nov 2019 A1
20190343641 Mauldin et al. Nov 2019 A1
20190343653 McKay Nov 2019 A1
20190388228 Donner et al. Dec 2019 A1
20200008817 Reiley et al. Jan 2020 A1
20200008850 Mauldin et al. Jan 2020 A1
20200222195 Assell et al. Jul 2020 A1
20200246158 Bergey Aug 2020 A1
20200261240 Mesiwala et al. Aug 2020 A1
20200268525 Mesiwala et al. Aug 2020 A1
20200276019 Shetty Sep 2020 A1
20200315647 Fojtik et al. Oct 2020 A1
20200315666 Nichols et al. Oct 2020 A1
20200345507 Reiley Nov 2020 A1
20200345508 Reiley Nov 2020 A1
20200345509 Reiley Nov 2020 A1
20200345510 Reiley Nov 2020 A1
20210153911 Stuart et al. May 2021 A1
20210169660 Reckling et al. Jun 2021 A1
20210212734 Mesiwala et al. Jul 2021 A1
20210228360 Hunt et al. Jul 2021 A1
20210338454 Afzal Nov 2021 A1
20210393408 Ginn Dec 2021 A1
20210393409 Ginn Dec 2021 A1
20220031474 Reckling et al. Feb 2022 A1
20220151668 Mauldin et al. May 2022 A1
20220273446 Stuart et al. Sep 2022 A1
20220273447 Ginn Sep 2022 A1
20220273448 Ginn et al. Sep 2022 A1
20220280303 Mauldin et al. Sep 2022 A1
20220296377 Ginn et al. Sep 2022 A1
20220296378 Ginn Sep 2022 A1
20220304813 Ginn et al. Sep 2022 A1
20220304814 Ginn Sep 2022 A1
20220409381 Ginn Dec 2022 A1
20230000630 Ginn et al. Jan 2023 A1
20230000631 Ginn et al. Jan 2023 A1
20230076180 Schifano et al. Mar 2023 A1
20230263554 Stuart et al. Aug 2023 A1
20230270559 Mesiwala et al. Aug 2023 A1
Foreign Referenced Citations (67)
Number Date Country
1128944 Aug 1996 CN
1190882 Aug 1998 CN
1909848 Feb 2007 CN
101795632 Aug 2010 CN
102361601 Feb 2012 CN
102429716 May 2012 CN
104968283 Oct 2015 CN
102011001264 Sep 2012 DE
102012106336 Jan 2014 DE
1287796 Mar 2003 EP
2070481 Feb 2012 EP
2796104 Oct 2014 EP
2590576 Oct 2015 EP
2749238 Mar 2017 EP
2887899 Aug 2017 EP
2341852 Aug 2018 EP
2496162 Oct 2018 EP
3616634 Mar 2020 EP
2408389 Apr 2021 EP
59200642 Nov 1984 JP
05-176942 Jul 1993 JP
05184615 Jul 1993 JP
09149906 Oct 1997 JP
10-85231 Apr 1998 JP
11318931 Nov 1999 JP
2002509753 Apr 2002 JP
2003511198 Mar 2003 JP
2003533329 Nov 2003 JP
2003534046 Nov 2003 JP
2004121841 Apr 2004 JP
2004512895 Apr 2004 JP
2004516866 Jun 2004 JP
2006506181 Feb 2006 JP
2007535973 Dec 2007 JP
2008540036 Nov 2008 JP
2009000501 Jan 2009 JP
2009521990 Jun 2009 JP
2009533159 Sep 2009 JP
2010137016 Jun 2010 JP
2012030105 Feb 2012 JP
2014000402 Jan 2014 JP
2015510506 Apr 2015 JP
2017528251 Sep 2017 JP
WO9731517 Aug 1997 WO
WO0117445 Mar 2001 WO
WO0238054 May 2002 WO
WO03007839 Jan 2003 WO
WO0402344 Jan 2004 WO
WO2004043277 May 2004 WO
WO2005009729 Feb 2005 WO
WO2006003316 Jan 2006 WO
WO2006023793 Mar 2006 WO
WO2006074321 Jul 2006 WO
WO2006116850 Nov 2006 WO
WO2009025884 Feb 2009 WO
WO2009029074 Mar 2009 WO
WO2010105196 Sep 2010 WO
WO2011010463 Jan 2011 WO
WO2011110865 Sep 2011 WO
WO2011124874 Oct 2011 WO
WO2011149557 Dec 2011 WO
WO2012015976 Feb 2012 WO
WO2012048008 Apr 2012 WO
WO2013000071 Jan 2013 WO
WO2013052807 Apr 2013 WO
WO2013119907 Aug 2013 WO
WO2014145902 Sep 2014 WO
Non-Patent Literature Citations (20)
Entry
Sand et al.; U.S. Appl. No. 17/447,550 entitled “Systems and methods for decorticating the sacroloac joint,” filed Sep. 13, 2021.
ACUMED; Acutrak Headless Compressioin Screw (product information); 12 pgs; © 2005; retrieved Sep. 25, 2014 from http://www.rcsed.ac.uk/fellows/lvanrensburg/classification/surgtech/acumed/manuals/acutrak-brochure%200311.pdf.
Al-Khayer et al.; Percutaneous sacroiliac joint arthrodesis, a novel technique; J Spinal Disord Tech; vol. 21; No. 5; pp. 359-363; Jul. 2008.
Khurana et al.; Percutaneous fusion of the sacroiliac joint with hollow modular anchorage screws, clinical and radiological outcome; J Bone Joint Surg; vol. 91-B; No. 5; pp. 627-631; May 2009.
Lu et al.; Mechanical properties of porous materials; Journal of Porous Materials; 6(4); pp. 359-368; Nov. 1, 1999.
Peretz et al.; The internal bony architecture of the sacrum; Spine; 23(9); pp. 971-974; May 1, 1998.
Richards et al.; Bone density and cortical thickness in normal, osteopenic, and osteoporotic sacra; Journal of Osteoporosis; 2010(ID 504078); 5 pgs; Jun. 9, 2010.
Wise et al.; Minimally invasive sacroiliac arthrodesis, outcomes of a new technique; J Spinal Disord Tech; vol. 21; No. 8; pp. 579-584; Dec. 2008.
Mesiwala et al.; U.S. Appl. No. 17/649,265 entitled “Implants for spinal fixation and or fusion,” filed Jan. 28, 2022.
Mesiwala et al.; U.S. Appl. No. 17/649,296 entitled “Implants for spinal fixation and or fusion,” filed Jan. 28, 2022.
Mauldin et al.; U.S. Appl. No. 17/650,473 entitled “Fenestrated implant,” filed Feb. 9, 2022.
Follini et al.; U.S. Appl. No. 17/777,679 entitled “Rod coupling assemblies for bone stabilization constructs,” filed May 18, 2022.
Stuart et al.; U.S. Appl. No. 17/812,945 entitled “Sacro-iliac joint stabilizing implants and methods of implantation,” filed Jul. 15, 2022.
Mauldin et al.; U.S. Appl. No. 17/805,165 entitled “Systems, device, and methods for joint fusion,” filed Jun. 2, 2022.
Mauldin et al.; U.S. Appl. No. 17/822,360 entitled “Fenestrated implant,” filed Aug. 25, 2022.
Lindsey et al.; U.S. Appl. No. 18/066,872 entitled “Threaded implants and methods of use across bone segments,” filed Dec. 15, 2022.
Reiley et al.; U.S. Appl. No. 18/317,832 entitled “Implants for bone fixation or fusion,” filed May 15, 2023.
Stuart et al.; U.S. Appl. No. 18/356,880 entitled “Sacro-iliac join stabilizing implants and methods of implantation,” filed Jul. 21, 2023.
Mauldin et al.; U.S. Appl. No. 18/509,864 entitled “Systems, device, and methods for joint fusion,” filed Nov. 15, 2023.
Sand et al.; U.S. Appl. No. 18/527,030 entitled “Systems and methods for decorticating the sacroiliac joint,” filed Dec. 1, 2023.
Related Publications (1)
Number Date Country
20220117640 A1 Apr 2022 US
Provisional Applications (1)
Number Date Country
62052379 Sep 2014 US
Continuations (3)
Number Date Country
Parent 16263971 Jan 2019 US
Child 17443388 US
Parent 15593208 May 2017 US
Child 16263971 US
Parent 14859005 Sep 2015 US
Child 15593208 US